-
Rosenior says Chelsea owners supportive despite slump
-
Oil jumps on Hormuz tensions, stocks retreat
-
Romania legend Hagi eyes 'winning every game' on return as coach
-
Rana stars as Bangladesh down New Zealand to level ODI series at 1-1
-
Real Madrid coach Arbeloa launches stout defence of Mbappe
-
Pope Leo blasts 'exploitation' on visit to resource-rich Angola
-
Amy Winehouse's father loses suit against friends selling her clothes
-
Japan issues warning after 7.7-magnitude quake hits north
-
UniCredit woos Commerzbank shareholders in takeover battle
-
European stocks slide as oil jumps on Hormuz tensions
-
Amy Winehouse's dad loses suit against friends for selling clothes
-
Slovenian liberal Golob fails to form government
-
Elon Musk summoned over French X deepfake probe but presence unclear
-
Tsunami warning as major quake hits northern Japan, shakes Tokyo
-
Rana takes 5-32 as Bangladesh bowl out New Zealand for 198
-
Anthropic says will put AI risks 'on the table' with Mythos model
-
Iran says no plan for US peace talks
-
Iran executes two more members of exiled opposition: group
-
Pope Leo visits Angola's diamond-rich northeast
-
US begins 'biggest ever' Philippines war games in thick of Mideast conflict
-
Bulgaria ex-president wins parliamentary majority
-
US begins 'biggest ever' Philippines war games in thick of Mideast war
-
Anxiety lingers in divided Kashmir a year after shooting attack
-
Hit reality show helps rev up Japan's delinquent youth subculture
-
Oil prices bounce back on Iran war escalation
-
Residents return to ravaged homes months after Hong Kong fire
-
Australia's Green wins playoff for third LPGA LA Championship title
-
Pakistan's military chief takes lead on US-Iran talks in diplomatic blitz
-
Thunder, Celtics open NBA playoffs with big wins, Magic shock Pistons
-
US begins Philippines war games in thick of Middle East conflict
-
Who's Bad? Not Michael Jackson in new big-budget biopic
-
Nations gather for first-ever conference on fossil fuel exit
-
Money, lobbyists, inertia: why fossil fuels are so hard to quit
-
France summons Elon Musk over X probe
-
'Save humanity': Four figures battling it out to lead embattled UN
-
Gilgeous-Alexander, Wemby, Jokic finalists for NBA MVP
-
Israel vows to level homes in Lebanon, counter threats with 'full force'
-
Research Pages Built Around the Metrics Self-Directed Investors Actually Use
-
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
-
Fast Finance Pay Corp. Launches OK.pay, Advancing OK.secure Into Scalable Payments Ecosystem
-
MMJ International Holdings Joins Federal Lawsuit on 4/20 to Stop CMS From Introducing Unvalidated Cannabinoid Products Into America's 65+ Population
-
Snapshot Recipes AI Mobile App Celebrates Approved Feature-Rich Update and AI Marketing Expansion
-
GA-ASI Completes MQ-9B 'Flight Into Known Icing' Flight Tests
-
Snaplii Reimagines Its Identity and Its Role in Redefining the Future of Finance
-
Peoples Bancorp Announces First Quarter 2026 Results
-
Elektros Inc. Positioned at the Center of a Multi-Billion Dollar EV Infrastructure Opportunity with Patented Charging Technology
-
Ondas Receives $10 Million Initial Order, Part of a $50 Million Award, to Launch Large-Scale Border Demining Program Along Israel's Eastern Border
-
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
-
TripSitter Announces Discovery Notice
-
Global Industrial to Report First Quarter 2026 Results on May 5, 2026
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.
Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.
Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
About Aprecia
Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.
Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.
About Apprentice
Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.
Contact Information:
Kristen Kucks
Director of Communications, Marketing
[email protected]
Justin Foreman
[email protected]
SOURCE: Apprentice.io
View the original press release on ACCESS Newswire
T.Ward--AMWN